Core Insights - The Hong Kong stock market showed mixed performance this week, with significant rebounds in the pharmaceutical sector and active performance in the new consumption sector, while popular technology stocks experienced varied movements [1] - The CSI Hong Kong Stock Connect Pharmaceutical and Health Index rose by 6.9%, and the CSI Hong Kong Stock Connect Consumption Theme Index increased by 2.3%, while the Hang Seng Technology Index fell by 0.4% [1][3] Index Performance - The Hang Seng New Economy Index increased by 0.7%, while the Hang Seng Technology Index decreased by 0.4% [3] - The rolling price-to-earnings (P/E) ratios for the indices are as follows: Hang Seng New Economy Index at 24.7x, Hang Seng Technology Index at 23.1x, CSI Hong Kong Stock Connect Pharmaceutical and Health Index at 29.2x, CSI Hong Kong Stock Connect Internet Index at 24.2x, and CSI Hong Kong Stock Connect Consumption Theme Index at 21.6x [3] - The rolling P/E ratio percentiles indicate that the Hang Seng New Economy Index is at 54.1%, the Hang Seng Technology Index at 30.8%, the CSI Hong Kong Stock Connect Pharmaceutical and Health Index at 46.0%, the CSI Hong Kong Stock Connect Internet Index at 23.0%, and the CSI Hong Kong Stock Connect Consumption Theme Index at 21.4% [3] Market Outlook - Western Securities noted that the reopening of the U.S. government and the resumption of spending by the Treasury could lead to a loosening of dollar liquidity, potentially driving a rebound in the Hong Kong stock market, with the Hang Seng Technology Index expected to benefit from a new round of strong rebound [1]

Market Overview - The Hong Kong stock market experienced a decline today, with the Hang Seng Index closing at 26,572.46 points, down 500.57 points, representing a drop of 1.85% [2] - The Hang Seng Technology Index also fell, closing at 5,812.80 points, down 168.50 points, a decrease of 2.82% [5] Sector Performance - Technology stocks faced widespread declines, with Baidu Group-SW (09888.HK) dropping over 7%, JD Group-SW (09618.HK) down over 6%, and Alibaba-W (09988.HK) falling over 4% [5] - The lithium battery sector saw significant losses, with Tianqi Lithium (09696.HK) down over 4% and Ganfeng Lithium (01772.HK) down over 3% [5] - Chinese brokerage stocks weakened, with CITIC Securities (06030.HK) declining over 4% [5] - Conversely, the innovative drug sector saw gains, with Gilead Sciences-B (01672.HK) rising over 15%. The innovative drug sector reported a 36% year-on-year revenue growth in Q3, with continued quarter-on-quarter growth [5] Capital Flow - After a small net sell-off of southbound funds yesterday, there was a return of capital today, with a cumulative net purchase of Hong Kong stocks reaching 12.8 billion HKD by the end of the trading day [6] Future Outlook - Western Securities noted that the reopening of the U.S. government and the return of liquidity from the Federal Reserve could lead to a significant reversal of previous pessimistic trading assumptions. This may provide a larger rebound space for risk assets that had previously declined due to tightened liquidity [8] - The report suggests that the Hong Kong market, particularly the Hang Seng Technology Index, may benefit from this shift in liquidity, potentially leading to a strong rebound [8] - The current effective investment strategy is to maintain a positive yet cautious approach, focusing on balanced allocation and avoiding chasing high prices, while being vigilant about external factors such as U.S. Federal Reserve policies and U.S.-China relations [8]